TrialThe Pediatric infectious disease journal2020

Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2).

Jeffrey Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.